Kurt F. Somerville’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-3,730
Closed -$371K 102
2019
Q3
$371K Sell
3,730
-2,715
-42% -$258K 0.07% 75
2019
Q2
$596K Sell
6,445
-6,296
-49% -$598K 0.12% 63
2019
Q1
$1.2M Sell
12,741
-75
-0.6% -$6.56K 0.24% 49
2018
Q4
$822K Sell
12,816
-27,530
-68% -$2.03M 0.19% 55
2018
Q3
$3.61M Buy
40,346
+4,200
+12% +$371K 0.72% 35
2018
Q2
$2.87M Buy
36,146
+19,035
+111% +$1.58M 0.63% 37
2018
Q1
$1.53M Buy
17,111
+12,391
+263% +$1.19M 0.34% 43
2017
Q4
$493K Buy
+4,720
New +$533K 0.1% 80

Other funds holding CELG

Kurt F. Somerville's CELG Position: Q4 2019 in Review

Kurt F. Somerville sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 3,730 shares — an estimated $371K sold.

Kurt F. Somerville first reported a position in CELG in Q4 2017 and held it in 8 quarters. The position peaked at $3.61M in Q3 2018. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Kurt F. Somerville reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Kurt F. Somerville sold 3,730 Celgene Corp shares in Q4 2019, an estimated $371K.
  • Kurt F. Somerville first reported a position in Celgene Corp in Q4 2017 and held it in 8 quarters.
  • Kurt F. Somerville's Celgene Corp position peaked at $3.61M in Q3 2018.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Kurt F. Somerville's 13F filing for Q4 2019, filed 15 Jan 2020.